We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

AFTER THE FRACTURE If you have recently broken a bone, you have come to the right place! The information that follows will help you to understand the pain that you […]

Dr. Adrian Lau, Dr. Rowena Ridout, Dr. Claudia Gagnon, Dr. Zahra Bardai, and Dr. Emma Billington. Recommendations from Osteoporosis Canada Rapid Response Team. The Canadian Centre on Substance Use and […]

Privacy Policy Our Commitment Osteoporosis Canada is committed to protecting the privacy of the personal information of its members, customers and other stakeholders. We value the trust of those we deal […]

I am 75 years old. Six months ago, I thought that “zoom” was a word that little boys and girls used when they were playing with toy cars. However, since […]

Support groups, one of the online programs offered by Osteoporosis Canada, are all about connection. They connect people who not only live with osteoporosis but want to live well with […]

SERMS Selective Estrogen Receptor Modulators Raloxifene (Evista®) is from a family of drugs called SERMs (Selective Estrogen Receptor Modulators). How Does Raloxifene Work? During their reproductive years, women produce significant […]

Available Volunteer Opportunities Support Group Facilitator – Virtual Support Group Facilitators work together with the Community Engagement Coordinators and are an integral part in the delivery of support services. Groups […]

Prepared and reviewed by members of the Scientific Advisory Council of Osteoporosis Canada Calcium is essential for the achievement and maintenance of normal bone health. The current daily requirements for […]